Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.00%
)
US TECH 100
24,101.20
(
-0.13%
)
Dow Jones
46,993.26
(
0.00%
)
Brent Oil
104.51
(
3.84%
)
Bitcoin
72,397.76
(
-2.09%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

rkrw

Send PM Follow Ignore
Followers 45
Posts 3206
Boards Moderated 0
Alias Born 12/29/2003

rkrw

Member Level

Re: DewDiligence post# 69746

Tuesday, 12/09/2008 3:30:59 PM

Tuesday, December 09, 2008 3:30:59 PM

Post# of 257253
Mrk did say they expect 5 more in pivotal studies by 2012. epo is just first. I wouldn't call it flagship. Merck name provides credibility. Who would you rather provide your generic epo, Insmed or Merck?

The company that's screwed by this is Affymax.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now